Hydrochloric Acid

Hydrochloric Acid

SCHEMBL5845845

Cl.c1ccc(CNCCNCc2ccccc2)cc1

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.94
KMT2A Q03164 1/20 0.94
TDP1 Q9NUW8 1/20 0.94
MAPT P10636 3/20 0.77
GAA P10253 1/20 0.77
MAOA P21397 1/20 0.73
CHRM2 P08172 1/20 0.70
SIGMAR1 Q99720 3/20 0.64
DRD4 P21917 1/20 0.59
SMN1; SMN2 Q16637 1/20 0.59
CYP3A4 P08684 2/20 0.56
KDM4E B2RXH2 1/20 0.56
MPO P05164 1/20 0.55
DPP7 Q9UHL4 1/20 0.55
PKM P14618 1/20 0.54
IDO1 P14902 2/20 0.52
THRB P10828 1/20 0.52
ADH1B P00325 1/20 0.52
ADH1C P00326 1/20 0.52
ADH1A P07327 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL11324591 1.00 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
SCHEMBL5764 0.97 MEN1 (1.00) MEN1KMT2ATDP1MAPTGAA
Arsenic SCHEMBL28302928 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
Water SCHEMBL4230715 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
Ammonia Solution, Strong SCHEMBL6678345 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
SCHEMBL4913828 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
SCHEMBL5040570 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
SCHEMBL4922899 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
Ammonia Solution, Strong SCHEMBL28179631 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA
SCHEMBL4969293 0.94 MEN1 (0.94) MEN1KMT2ATDP1MAPTGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109651403-B Synthesis method of cefoxitin sodium 上海上药新亚药业有限公司 2022-01-07 CN claimed
CN-108752216-B Green preparation method of high-purity N, N' -dibenzyl ethylenediamine diacetic acid 重庆天地药业有限责任公司 2021-07-16 CN claimed
US-7071329-B2 Process for preparing cephalosporins with salified intermediate ACS DOBFAR S.P.A. (IT) 2006-07-04 US claimed
US-20050119244-A1 Process for preparing cephalosporins with salified intermediate ACS DOBFAR S.P.A. (IT) 2005-06-02 US claimed
US-20050119478-A1 Process for preparing cephalosporins with salified intermediate ACS DOBFAR S.P.A. (IT) 2005-06-02 US claimed
CN-116283600-A Recovery method and application of N, N-benzyl ethylenediamine salt 浙江东盈药业有限公司 2023-06-23 CN disclosed
US-20230192591-A1 PROCESS FOR PREPARING TRIENTINE DIHYDROCHLORIDE COUGHLIN DANIEL J (US) 2023-06-22 US disclosed
CN-109651403-B Synthesis method of cefoxitin sodium 上海上药新亚药业有限公司 2022-01-07 CN disclosed
WO-2021195671-A1 PROCESS FOR PREPARING TRIENTINE DIHYDROCHLORIDE JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 2021-09-30 WO disclosed
US-20210238318-A1 COMPOSITE FUNCTIONAL RESIN, PREPARATION METHOD THEREFOR AND USE THEREOF NANJING UNIVERSITY & YANCHENG ACADEMY OF ENVIRONMENTAL PROTECTION TECHNOLOGY AND ENGINEERING (CN) 2021-08-05 US disclosed
CN-111217836-A Preparation method of cefoxitin 侯二美 2020-06-02 CN disclosed
US-7071329-B2 Process for preparing cephalosporins with salified intermediate ACS DOBFAR S.P.A. (IT) 2006-07-04 US disclosed
US-20050119244-A1 Process for preparing cephalosporins with salified intermediate ACS DOBFAR S.P.A. (IT) 2005-06-02 US disclosed
US-20050119478-A1 Process for preparing cephalosporins with salified intermediate ACS DOBFAR S.P.A. (IT) 2005-06-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119478-A1 Process for preparing cephalosporins with salified intermediate TST, TREH, STS MEN1 1928/4885KMT2A 3280/4885TDP1 4567/4885
US-20230192591-A1 PROCESS FOR PREPARING TRIENTINE DIHYDROCHLORIDE SAMHD1, QDPR, DHPS MEN1 1968/4885KMT2A 3779/4885TDP1 3410/4885
US-20210238318-A1 COMPOSITE FUNCTIONAL RESIN, PREPARATION METHOD THEREFOR AND USE THEREOF ATP5F1C, ATP5MF, ATP5F1B MEN1 4220/4885KMT2A 3670/4885TDP1 2731/4885
US-20050119244-A1 Process for preparing cephalosporins with salified intermediate ACACA, ACACB, COASY MEN1 2712/4885KMT2A 2014/4885TDP1 3997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.